Episode 31: David Mitchell & Patients For Affordable Drugs
jonstrum
In 2004, the average wholesale price of available MS disease-modifying therapies was $16,000. In 2013, the average price was $61,000; last year, the average price was more than $83,000. That's why I was anxious to bring on my guest this week, David Mitchell, the founder and president of Patients for Affordable Drugs.
We're also talking about the RealTalk MS Podcast Alexa Skill! If you already own an Amazon Echo, Dot, or any Alexa-enabled device, you can access all sorts of convenient features for listening to RealTalk MS! (And if you don't yet have an Alexa-enabled device, this might be one more reason to get one!)
A new study concludes that Autologous Haematopoietic Stem Cell Therapy is safe and effective in treating ‘aggressive' MS. Another pilot study demonstrates that aspirin can help prevent the onset of overheating and exhaustion following exercise. And your future appointments with your neurologist may take place from the comfort of your own home.
We have a lot to talk about! Are you ready for RealTalk MS?
____________
Our Alexa Announcement :27
Study Shows Autologous Hematopoietic Stem Cell Therapy Safe & Effective In Treating “Aggressive” MS 4:40
Overheating When You Exercise? Study Recommends Taking 2 Aspirin 8:06
How About Having Your Next Appointment With Your Neurologist At Home? 10:15
Interview with David Mitchell 13:00
___________
LINKS If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com
